Jeffrey Bradley

Jeffrey Bradley

Emory University

H-index: 87

North America-United States

About Jeffrey Bradley

Jeffrey Bradley, With an exceptional h-index of 87 and a recent h-index of 55 (since 2020), a distinguished researcher at Emory University, specializes in the field of lung cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

NRG Oncology and PTCOG Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated …

LBA1 Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III NSCLC: Final results from PACIFIC-2

Factors Associated with and Characteristics of Patients Receiving Proton Therapy at the End Of Life

The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC

Implementation of a Novel Chart Rounds Application to Facilitate Peer Review in a Virtual Academic Environment

Immune system dose with proton vs photon radiotherapy for treatment of locally advanced NSCLC

Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint …

Deformable lung 4DCT image registration via landmark‐driven cycle network

Jeffrey Bradley Information

University

Position

Professor of Radiation Oncology

Citations(all)

30472

Citations(since 2020)

14120

Cited By

21814

hIndex(all)

87

hIndex(since 2020)

55

i10Index(all)

269

i10Index(since 2020)

207

Email

University Profile Page

Google Scholar

Jeffrey Bradley Skills & Research Interests

lung cancer

Top articles of Jeffrey Bradley

Title

Journal

Author(s)

Publication Date

NRG Oncology and PTCOG Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated …

International Journal of Radiation Oncology Biology Physics

Wei Liu

Hongying Feng

Paige A Taylor

Minglei Kang

Jiajian Shen

...

2024

LBA1 Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III NSCLC: Final results from PACIFIC-2

ESMO Open

JD Bradley

S Sugawara

KHH Lee

G Ostoros

A Demirkazik

...

2024/3/1

Factors Associated with and Characteristics of Patients Receiving Proton Therapy at the End Of Life

International Journal of Particle Therapy

Mina Bakhtiar

Anish A Butala

Eva E Berlin

James M Metz

Jeffrey D Bradley

...

2024/4/23

The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC

Radiotherapy and Oncology

Cole Friedes

Michelle Iocolano

Sang Ho Lee

Lian Duan

Bolin Li

...

2024/1/1

Implementation of a Novel Chart Rounds Application to Facilitate Peer Review in a Virtual Academic Environment

Advances in Radiation Oncology

Naba Ali

Eduard Schreibmann

Oluwatosin Kayode

Ashish Patel

Pretesh Patel

...

2024/3/1

Immune system dose with proton vs photon radiotherapy for treatment of locally advanced NSCLC

International Journal of Particle Therapy

Jimmy S Patel

Neal S McCall

Matthew Thomas

Jun Zhou

Kristin A Higgins

...

2024/4/23

Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint …

Radiotherapy and Oncology

Nikhil Yegya-Raman

Sang Ho Lee

Cole Friedes

Xingmei Wang

Michelle Iocolano

...

2024/1/1

Deformable lung 4DCT image registration via landmark‐driven cycle network

Medical Physics

Luke Matkovic

Yang Lei

Yabo Fu

Tonghe Wang

Aparna H Kesarwala

...

2024/3

Patterns of failure, low-volume relapse, and subsequent ablative management in locally advanced non-small cell lung cancer treated with definitive chemoradiation and …

International Journal of Radiation Oncology* Biology* Physics

Cole Friedes

Michelle Iocolano

Sang Ho Lee

Bolin Li

Lian Duan

...

2024/4/1

Proton Pencil-Beam Scanning Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies: Patterns of Practice Survey and …

Wei Liu

Hongying Feng

Paige A Taylor

Minglei Kang

Jiajian Shen

...

2024/2/22

Pneumonitis rates before and after adoption of immunotherapy consolidation in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiation

International Journal of Radiation Oncology* Biology* Physics

Nikhil Yegya-Raman

Cole Friedes

Sang Ho Lee

Michelle Iocolano

Lian Duan

...

2024/4/1

Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era

Cancer

Michelle Iocolano

Nikhil Yegya‐Raman

Cole Friedes

Xingmei Wang

Timothy Kegelman

...

2024/1/31

FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach

JMIR Research Protocols

Emily C Daugherty

Anthony Mascia

Yong Zhang

Eunsin Lee

Zhiyan Xiao

...

2023/1/5

Phase 2 trial of consolidation pembrolizumab after proton reirradiation for thoracic recurrences of non-small cell lung cancer

International Journal of Radiation Oncology* Biology* Physics

Nikhil Yegya-Raman

Abigail T Berman

Christine A Ciunci

Cole Friedes

Eva Berlin

...

2024/5/1

Lung SBRT treatment planning: a study of VMAT arc selection guided by collision check software

Medical Dosimetry

Tyrone Hamilton

Jiahan Zhang

Jonathan Wolf

Oluwatosin Kayode

Kristin A Higgins

...

2023/6/1

Benchmarking the Radiation Oncology Alternative Payment Model: Changes in Medicare Reimbursement for 16 Common Radiation Therapy Treatment Courses

Practical Radiation Oncology

Jacob S Hogan

Patricia Karraker

Benjamin W Fischer-Valuck

Neha Vapiwala

Minesh P Mehta

...

2023/9/1

The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC

Cancer Research Communications

Joanne B Weidhaas

Chen Hu

Ritsuko Komaki

Gregory A Masters

George R Blumenschein

...

2023/10/11

OA17. 05 Association Between Pre-Treatment Circulating Immune Biomarkers And Survival In Stage III NSCLC: A Translational Analysis From NRG-RTOG 0617

Journal of Thoracic Oncology

M Machtay

C Hu

TD Schell

JD Bradley

GH Perdew

...

2023/11/1

In Memoriam: Dr Carlos A. Pérez—A Trailblazing Legacy of Healing and Innovation

International Journal of Radiation Oncology, Biology, Physics

Jeff M Michalski

Sasa Mutic

James A Purdy

Dennis E Hallahan

Jeffrey D Bradley

2023/12/1

Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: the FAST-01 nonrandomized trial

JAMA oncology

Anthony E Mascia

Emily C Daugherty

Yongbin Zhang

Eunsin Lee

Zhiyan Xiao

...

2023/1/1

See List of Professors in Jeffrey Bradley University(Emory University)